Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 3/20 | 0.39 |
| ▸ | CES1 | P23141 | 3/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3639962 | 1.00 | TSHR (0.50) | TSHRTHRBCES2CES1EPHX2 | |
| SCHEMBL11118687 | 1.00 | TSHR (0.50) | TSHRTHRBCES2CES1EPHX2 | |
| SCHEMBL9936661 | 1.00 | TSHR (0.50) | TSHRTHRBCES2CES1EPHX2 | |
| SCHEMBL10790190 | 1.00 | TSHR (0.50) | TSHRTHRBCES2CES1EPHX2 | |
| SCHEMBL940782 | 1.00 | TSHR (0.50) | TSHRTHRBCES2CES1EPHX2 | |
| SCHEMBL20603 | 0.97 | — | — | |
| SCHEMBL777624 | 0.87 | — | — | |
| SCHEMBL8861895 | 0.84 | TSHR (0.33) | TSHRTHRB | |
| SCHEMBL29286279 | 0.75 | TSHR (0.89) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL29286267 | 0.75 | TSHR (0.89) | TSHRTHRBDNM1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1077 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12516011-B2 | Method of producing higher alkanones, preferably 6-undecanone, and derivatives thereof | EVONIK OPERATIONS GMBH (DE) | 2026-01-06 | — | — | US | claimed |
| CN-119931634-A | Amphiphilic quantum dot composite microsphere and preparation method thereof | 济南玖方生物科技有限公司 | 2025-05-06 | — | — | CN | claimed |
| WO-2024212083-A1 | METHOD FOR EFFICIENTLY RECOVERING LITHIUM FROM LITHIUM-DEPOSITED MOTHER LIQUOR | 广东邦普循环科技有限公司 | 2024-10-17 | — | — | WO | claimed |
| EP-4153557-B1 | METHOD FOR PRODUCING HIGHER LINEAR FATTY ACIDS OR ESTERS | EVONIK OPERATIONS GMBH (DE) | 2024-07-03 | — | — | EP | claimed |
| US-20240191264-A1 | METHOD FOR PRODUCING HIGHER LINEAR ALKANES | EVONIK OPERATIONS GMBH (DE) | 2024-06-13 | — | — | US | claimed |
| CN-117926003-A | Extractant for battery-grade manganese sulfate and preparation method thereof | 金族(兰州)精细化工有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-117783319-A | Method for detecting tri-n-octyl phosphine residual quantity in bulk drug by gas chromatography technology | 常州合全药业有限公司 | 2024-03-29 | — | — | CN | claimed |
| EP-4314309-A2 | METHOD FOR PRODUCING HIGHER LINEAR ALKANES | Evonik Operations GmbH (DE) | 2024-02-07 | — | — | EP | claimed |
| CN-117120400-A | Process for producing higher linear alkanes | 赢创运营有限公司 | 2023-11-24 | — | — | CN | claimed |
| CN-116829509-A | Method for efficiently recycling lithium from lithium precipitation mother solution | 广东邦普循环科技有限公司 | 2023-09-29 | — | — | CN | claimed |
| EP-1328532-A2 | PRODUCTION OF METAL CHALCOGENIDE NANOPARTICLES | Oxonica Limited (GB) | 2003-07-23 | — | — | EP | claimed |
| US-6399840-B1 | REACTING CARBON TETRACHLORIDE WITH 2-CHLORO-1-PROPENE IN PRESENCE OF TELOMERIZATION CATALYSTE | SOLVAY (SOCIETE ANONYME) (BE) | 2002-06-04 | — | — | US | claimed |
| WO-2002034757-A2 | PRODUCTION OF METAL CHALCOGENIDE NANOPARTICLES | OXONICA LIMITED (GB) | 2002-05-02 | — | — | WO | claimed |
| CN-1261339-A | Method for preparing 1,1,1,3, 3-pentachlorobutane | SOLVAY (BE) | 2000-07-26 | — | — | CN | claimed |
| US-5188736-A | Using 2-methoxyethanol and/or ethylene glycol as polar separating agent | INSTITUTE OF NUCLEAR ENERGY RESEARCH (TW) | 1993-02-23 | — | — | US | claimed |
| US-4950781-A | REACTING AN ALKALI METAL MALT OF PHENOL WITH CARBON DI OXIDE IN PRESENCE OF PHOSPHINE OXIDE SOLVENT | MITSUI TOATSU CHEMICALS, INC. (JP) | 1990-08-21 | — | — | US | claimed |
| EP-0304149-A2 | High-solids coating compositions | MOONEY CHEMICALS, INC. (US) | 1989-02-22 | — | — | EP | claimed |
| US-4595415-A | Adding oxidative catalyst complex of trioctylphosphine oxides and carboxylic acid manganese salt to polyunsaturated oil | LINDSAY FINISHES, INC. (US) | 1986-06-17 | — | — | US | claimed |
| US-4406865-A | BINDING, STRIPPING | EXXON RESEARCH AND ENGINEERING CO. (US) | 1983-09-27 | — | — | US | claimed |
| US-4248703-A | Emulsion removal from acidic solution-solvent interfaces | WYOMING MINERAL CORPORATION (US) | 1981-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240191264-A1 | METHOD FOR PRODUCING HIGHER LINEAR ALKANES | ALKBH3, ALKBH1, AKR7A2 | TSHR 4762/4885THRB 4698/4885CES2 483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.